

Informação sobre produto
Nome:CDK-IN-2
Marca:Biosynth
Descrição:CDK-IN-2 is a novel small molecule that inhibits the activity of CDKs, which are enzymes involved in regulating the cell cycle. It has potent antagonist effects against CDKs and can be used to treat bowel diseases, such as colitis. CDK-IN-2 also has hematologic responses and is effective in treating carcinoid syndrome and autoimmune diseases. This drug has been shown to have an interactive response with magnesium salt, which may be due to its ability to inhibit the ryanodine receptor.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:363.81 g/mol
Fórmula:C18H19ClFN3O2
Pureza:Min. 95%